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Gouty arthritis is uncommon in childhood and adolescence. On the other hand, there has been no report of cases
with development of gouty arthritis with post-streptococcal acute glomerulonephritis (PSAGN) in pediatric patients.
Here we report the case of a mildly obese 12-year-old boy with PSAGN complicated by gouty arthritis of the left
first metatarsophalangeal joint. On follow-up, it was confirmed that as serum C3 level returned to normal, urinary
excretion of uric acid increased and serum uric acid level decreased, thereby resolving the burning pain of the left
big toe. In this case, not only did renal insufficiency associate with PSAGN but also mild obesity may have led to
hyperuricemia and gouty arthritis. In conclusion, clinicians should be aware that PSAGN may be complicated by
gouty arthritis in obese pediatric patients.
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Gout is a common medical problem [1, 2] that usually
develops after middle age. Juvenile gouty arthritis, on the
other hand, is a less common disease [3]. Hyperuricemia
is known to be moderately to highly associated with renal
dysfunction [4] and chronic glomerulonephritis in adults
is often accompanied by hyperuricemia that results from
decline in glomerular filtration rate (GFR) [5]. However,
there have been no reports of cases with development of
gouty arthritis with post-streptococcal acute glomerulo-
nephritis (PSAGN) in pediatric patients. We describe the
case of a mildly obese 12-year-old boy with PSAGN
that was complicated by gouty arthritis of the left first
metatarsophalangeal joint (MTP1). In obese patients,
gouty arthritis may be induced by the renal insufficiency
associated with PSAGN. Furthermore, in this paper, we
report time-related changes in serum uric acid (UA) level,
urinary excretion of UA (UA/creatinine ratio), and serum
C3 level during follow-up of this patient.Case presentation
A 12-year-old Japanese boy with mild obesity but without
significant medical history was admitted to our hospital
because of hematuria, proteinuria, edema, and wet cough.* Correspondence: yasutakakuniyoshi@yahoo.co.jp
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creativecommons.org/publicdomain/zero/1.0/He was a member of the sumo (Japanese-style wrestling)
team in junior high school. Four days before admission,
he took an antimicrobial agent for pharyngitis. After
2 days, he was noted to have abdominal pain, edema of
the legs, and burning pain of the left big toe. His family
did not have a history of hyperuricemia or gouty arthritis.
On examination, his temperature was 36.8 °C, blood
pressure was 160/92 mmHg, heart rate was 86 beats/min,
respiratory rate was 22 breaths/min, oxygen saturation
while breathing ambient air was 93 %; he weighed 84.9 kg
(BMI 31 kg/m2) and was 165.1 cm tall. There was redness,
swelling, and tenderness of the left MTP1 on light touch
(Fig. 1). He was ambulatory but with conscious effort to
avoid loading the left lower extremity with his body
weight. Severe edema of both eyelids and lower legs was
observed. The remainder of the examination was normal.
Laboratory examination revealed white blood cell count
of 10900/μL, hemoglobin of 10.6 g/dL, hematocrit of
31.0 %, platelet count of 265000/μL, serum total protein
level of 6.7 g/dL, albumin level of 3.1 g/dL, blood urea
nitrogen (BUN) level of 30.8 mg/dL, serum creatinine
level of 1.20 mg/dL, serum UA level of 10.5 mg/dL
(reference range, <7.0 mg/dL), C-reactive protein level
of 2.5 mg/dL (reference range, <3.0 mg/dL), C3 level of
25 mg/dL (reference range, 65–135 mg/dL), C4 level of
17 mg/dL (reference range, 13–35 mg/ dL), complement
activities (CH50) level of 10U/mL (reference range, 29–48s article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Gouty arthritis complicating PSAGN in a 12-year-old boy. The
left MTP1 was swollen.
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range, 140–410 mg/ dL), and antistreptolysin O level of
628 IU/mL (reference range, <200 IU/mL). Dipstick
urinalysis showed 2+ for occult blood and 3+ for pro-
tein; red blood cell casts and a few granular, hyaline,
and erythrocyte casts were also observed. Group A
beta-hemolytic streptococci were isolated from his
throat culture. Computed tomography of the chest
showed pulmonary edema and bilateral pleural effusion.
Echocardiogram showed normal cardiac function and no
valve disease.
The patient was treated with water and sodium re-
striction, oxygen administration at 2 L/min, intravenous
furosemide, and oral amlodipine for hypertension and
pulmonary edema; intravenous minocycline was also
administered. He was initially treated for MTP1 gouty
arthritic pain with oral acetaminophen. However, because
of the persistence of pain, oral prednisolone (20 mg/day)
was added on the 9th day. In addition, intravenous
furosemide was discontinued because oxygen satur-
ation improved and his weight decreased to 80.3 kg.
On the 13th day, amlodipine was discontinued because
blood pressure stabilized, with systolic pressure less than
120 mmHg. On the 26th day, he was discharged from the
hospital; at this time, his body weight was 75.0 kg
(BMI 27 kg/m2). The pain of the left MTP1 gradually
improved and lasted for about 2 months after discharge.
Figure 2 illustrates the changes in serum UA levels,
UA/creatinine ratio, and serum C3 levels observed
during the follow-up period.
Conclusions
Juvenile gouty arthritis is a very rare disease [3]. The
course of this patient provides an example of PSAGN thatwas complicated by gouty arthritis in an obese pediatric
patient. In this case, gouty arthritis may have been
induced by overproduction and under excretion of
UA which were due to the renal insufficiency associated
with PSAGN and mild obesity.
It is known that serum UA level is indirectly propor-
tional to GFR in patients with chronic glomerulonephritis.
This is due to impaired UA excretion from the kidney.
Furthermore, it has been reported that hyperuricemia in
IgA nephropathy was caused by both glomerular and
tubulointerstitial damage [5]. We believe that hyperurice-
mia in PSAGN is caused by the same mechanism. Similar
cases of juvenile gouty arthritis associated with mild renal
insufficiency have been reported previously [6].
Our patient had probably been obese even before
his clinical symptoms developed because his BMI was
27 kg/m2 after resolution of edema. Sumo players generally
increase their body weight to gain an advantage. We
hypothesize that mild obesity could also lead to hyperurice-
mia and gouty arthritis. Chen SY et al. reported that obesity
could be responsible for the onset of hyperuricemia and
juvenile gouty arthritis, as exemplified by their Taiwanese
teenager patient [3]. Another case report [7] of a 15-year-
old obese boy with a BMI of 47.4 kg/m2 has also been
reported previously. The onset of gouty arthritis may
depend on the balance in the production and excretion rate
of UA [8]. Although our patient was mildly obese, we
believe that this balance may have been disrupted because
of the acute increase in serum UA level by PSAGN.
On follow-up, it was confirmed that as serum C3 level
returned to normal, urinary excretion of UA increased
and serum UA level decreased (Fig. 2-a, b). To the best
of our knowledge, this is the first report on time-related
changes in serum UA level, UA/creatinine, and serum
C3 level in PSAGN. These findings suggest that the main
mechanism of hyperuricemia in our patient was due to a
decrease in UA excretion from the kidney. Current
available evidence suggests that the major pathogenic
mechanism responsible for this change is immune complex
formation due to deposition of streptococcal nephritogenic
antigens within the glomerulus [9]. Glomerular immune
complexes activate the complement system and coagula-
tion cascade, resulting to diffuse endocapillary proliferation
and significant narrowing of the glomerular vessel lumen,
which leads to a reduction in GFR. After the acute
phase, glomerular immune complexes are cleared and the
complement system is deactivated.
Loop diuretics may have contributed to the persistent
pain on the MTP1 for almost two months. Diuretics,
which reduce UA excretion by affecting ion exchanger
proteins at the proximal tubule luminal membrane, are
commonly withheld in patients with hyperuricemia [10, 11].
However, in the present case, in which the patient had pul-





















































Fig. 2 a,b: Laboratory values on follow-up. Time-related changes in serum UA level, urinary UA/creatinine ratio, and serum C3 level
Kuniyoshi et al. Pediatric Rheumatology  (2015) 13:24 Page 3 of 4diuretics were necessary for fluid control. Therefore, in such
cases, it may be necessary to monitor and watch out for the
development of hyperuricemia.
This case report has some limitations. The diagnosis
of post-streptococcal reactive arthritis (PSRA), acuterheumatic fever, and another etiology could not be
excluded because synovial fluid analysis was not con-
ducted. He was not diagnosed as having acute rheumatic
fever according to the Jones criteria [12]. Simultaneous
development of PSRA and PSAGN after subclinical
Kuniyoshi et al. Pediatric Rheumatology  (2015) 13:24 Page 4 of 4streptococcal infection has been reported previously
[13, 14]. The characteristics of PSRA as nonmigratory and
persistent arthritis and tenosynovitis were applied to this
case as well. Without synovial fluid analysis, the diagnosis
of gouty arthritis was made according to the 1977 criteria
for classification of acute arthritis from primary gout
[15]. In reference to other clinical criteria reported by
Janssens et al. [16], the probability of gout in our patient
was more than 80 %, because of the presence of the
following clinical features: male sex, joint redness,
MTP1 involvement, and hyperuricemia [3].
In conclusion, clinicians must be aware that in obese
pediatric patients, PSAGN may be complicated by gouty
arthritis. In the future, we need to accumulate more cases
and analyze the serum UA level of PSAGN patients with
joint pain.
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